The use of extracorporeal membrane oxygenation in the treatment of critical course of pneumonia

Czech version

Authors: Samuel Genzor ¹; Martin Šimek ²; Petr Jakubec ¹; Pavol Pobeha ⁴; Jan Mizera ¹; Martin Vykopal ¹; Jakub Kiml ¹; Milan Sova ^1,3
Authors‘ workplace: Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc ¹; Kardiochirurgická klinika LF UP a FN Olomouc ²; Klinika nemocí plicních a tuberkulózy LF MU a FN Brno ³; Klinika pneumológie a ftizeológie LF UPJŠ a UNLP Košice ⁴
Published in: Čas. Lék. čes. 2022; 161: 321-324
Category: Review Article

Overview

Extracorporeal membrane oxygenation is the highest form of resuscitation care in management of patients with respiratory failure. In the case of acute respiratory distress syndrome, the veno-venous setting is more often used. ECMO support enables, in case of lung function failure, to obtain the necessary time for the onset of the causal treatment effect or is used as a bridge to transplantation Mortality of the patients varies according to the underlying cause and presence of risk factors (e.g., age, complications or comorbid diseases). The onset of the COVID-19 pandemic has led to a significant increase in the need for ECMO. The quality of life of patients after ECMO is significantly reduced, but most patients do not experience permanent disability.

Keywords:

COVID-19 – ECMO – long-term outcome

Sources

Allen S, Holena D, McCunn M et al. A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients. J Intensive Care Med 2011; 26: 13–26.
Lim H. The physiology of extracorporeal membrane oxygenation: the Fick principle. Perfusion 2021: 2676591211055971.
Makdisi G, Wang IW. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis 2015; 7: E166–E176.
Lee SH. Awakening in extracorporeal membrane oxygenation as a bridge to lung transplantation. Acute Crit Care 2022; 37: 26–34.
Supady A, Combes A, Barbaro RP et al. Respiratory indications for ECMO: focus on COVID-19. Intensive Care Med 2022; 48: 1326–1337.
Karagiannidis C, Brodie D, Strassmann S et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 2016; 42: 889–896.
Bergman ZR, Wothe JK, Alwan FS et al. The use of venovenous extracorporeal membrane oxygenation in COVID-19 infection: one region's comprehensive experience. ASAIO J 2021; 67: 503–510.
Harnisch LO, Moerer O. Contraindications to the initiation of veno-venous ECMO for severe acute respiratory failure in adults: a systematic review and practical approach based on the current literature. Membranes (Basel) 2021; 11: 584.
Rich PB, Awad SS, Crotti S et al. A prospective comparison of atrio-femoral and femoro-atrial flow in adult venovenous extracorporeal life support. J Thorac Cardiovasc Surg 1998; 116: 628–632.
Fisser C, Palmér O, Sallisalmi M et al. Recirculation in single lumen cannula venovenous extracorporeal membrane oxygenation: a non-randomized bi-centric trial. Front Med (Lausanne) 2022; 9: 973240.
Giani M, Martucci G, Madotto F et al. Prone positioning during venovenous extracorporeal membrane oxygenation in acute respiratory distress syndrome. A multicenter cohort study and propensity-matched analysis. Ann Am Thorac Soc 2021; 18: 495–501.
Gibbon JH. The artificial intracorporeal heart. Presidential address. Surgery 1996; 59: 1–5.
Kennedy JH. The role of assisted circulation in cardiac resuscitation. JAMA 1966; 197: 615–618.
Gattinoni L, Pesenti A, Mascheroni D et al. Low-frequency positive-pressure ventilation with extracorporeal CO₂ removal in severe acute respiratory failure. JAMA 1986; 256: 881–886.
Peek GJ, Mugford M, Tiruvoipati R et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351–1363.
Combes A, Hajage D, Capellier G et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378: 1965–1975.
Pappalardo F, Pieri M, Greco T et al. Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med 2013; 39: 275–281.
Daviet F, Guilloux P, Hraiech S et al. Impact of obesity on survival in COVID-19 ARDS patients receiving ECMO: results from an ambispective observational cohort. Ann Intensive Care 2021; 11: 157.
Herrmann J, Lotz C, Karagiannidis C et al. Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care 2022; 26: 190.
Steinbeis F, Thibeault C, Doellinger F et al. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: an observational longitudinal study over 12 months. Respir Med 2022; 191: 106709.
Ego A, Taton O, Brasseur A et al. Six-month pulmonary function after venovenous extracorporeal membrane oxygenation for coronavirus disease 2019 patients. Crit Care Explor 2021; 3: e0494.
Grasselli G, Scaravilli V, Tubiolo D et al. Quality of life and lung function in survivors of extracorporeal membrane oxygenation for acute respiratory distress syndrome. Anesthesiology 2019; 130: 572-–580.
Xu Z, Xu Y, Liu D et al. Case Report: Prolonged VV-ECMO (111 days) support in a patient with severe COVID-19. Front Med (Lausanne) 2021; 8: 681548.
Wiktor AJ, Haft JW, Bartlett RH et al. Prolonged VV ECMO (265 days) for ARDS without technical complications. ASAIO J 2015; 61: 205–206.
Umei N, Ichiba S, Sakamoto A. Idiopathic pulmonary fibrosis patient supported with extracorporeal membrane oxygenation for 403 days while waiting for a lung transplant: a case report. Respir Med Case Rep 2018; 24: 86–88.
Zangrillo A, Landoni G, Biondi-Zoccai G et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Criti Care Resusc 2013; 15: 172–178.
Stulak JM, Dearani JA, Burkhart HM et al. ECMO cannulation controversies and complications. Semin Cardiothorac Vasc Anesth 2009; 13: 176–182.
Kim JH, Pieri M, Landoni G et al. Venovenous ECMO treatment, outcomes, and complications in adults according to large case series: a systematic review. Int J Artif Organs 2021; 44: 481–488.
Saeed O, Tatooles AJ, Farooq M et al. Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: a retrospective multicenter study. J Thorac Cardiovasc Surg 2022; 163: 2107.e6–2116.e6.

Labels

Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management

ÚVODEM

The International Code of Medical Ethics of the World Medical Association

In 2022, a new version of the Code of Ethics was adopted by the World Medical Association (WMA) – what new features does it bring?

Ethical principles for the usage and sharing of genomic data from research

Indications for Metabolic and Bariatric Surgery – ASMBS/IFSO 2022

Innovative Bariatric Procedures and Ethics in Bariatric Surgery: the IFSO Position Statement

Practical recommendations for the management of children after kidney and liver transplantation

Permanent urethral catheter – a good servant, but bad master: Guidelines for prevention, diagnosis, and treatment of catheter-associated urinary tract infections

Prescription rules of hormone replacement therapy and its alternative

Low levels of vitamin D in population exposed to significant environmental pollution

COVID-19 infection elicits textbook immune response

Trends in spa and balneology in postcovid era, outcomes, and perspectives